Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C038864 |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in increased phosphorylation of TBC1D4 protein | increases phosphorylation | 18063688
|
C103303 |
alitretinoin |
alitretinoin results in increased phosphorylation of TBC1D4 protein | increases phosphorylation | 18063688
|
C103303 |
alitretinoin |
Oligomycins promotes the reaction [alitretinoin results in increased phosphorylation of TBC1D4 protein] | increases phosphorylation|increases reaction | 18063688
|
D001374 |
Azacitidine |
Azacitidine results in decreased expression of TBC1D4 mRNA | decreases expression | 19194470
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TBC1D4 mRNA | decreases expression | 19150397
|
C039671 |
ciglitazone |
ciglitazone results in increased phosphorylation of TBC1D4 protein | increases phosphorylation | 18063688
|
D003078 |
Colchicine |
Colchicine affects the phosphorylation of TBC1D4 protein | affects phosphorylation | 18063688
|
D003078 |
Colchicine |
Colchicine inhibits the reaction [Oligomycins results in increased phosphorylation of TBC1D4 protein] | decreases reaction|increases phosphorylation | 18063688
|
D009840 |
Oligomycins |
Colchicine inhibits the reaction [Oligomycins results in increased phosphorylation of TBC1D4 protein] | decreases reaction|increases phosphorylation | 18063688
|
D009840 |
Oligomycins |
Oligomycins promotes the reaction [alitretinoin results in increased phosphorylation of TBC1D4 protein] | increases phosphorylation|increases reaction | 18063688
|
D009840 |
Oligomycins |
Oligomycins results in increased phosphorylation of TBC1D4 protein | increases phosphorylation | 18063688
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of TBC1D4 mRNA | increases expression | 18301758
|
D019772 |
Topotecan |
TBC1D4 protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014747 |
Vinblastine |
TBC1D4 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.30 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.72 | 16434500 |
MESH:D001528 |
Behcet Syndrome |
|
Colchicine |
6.32 | 15870978 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.32 | 19483382 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
3.10 | 16344269 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
3.85 | 1485588 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.84 | 20889678 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.95 | 19176532 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.18 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.18 | 18802399 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.49 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.65 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
ciglitazone |
5.67 | 16844232 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.11 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.93 | 19236843 20131406 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.63 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.21 | 16221962 19772884 18467677 19176532 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
4.18 | 18180244 18501091 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.34 | 20558911 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.74 | 16306350 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.87 | 16144296 |
MESH:D007859 |
Learning Disorders |
|
Colchicine |
5.71 | 11749816 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
3.77 | 19148494 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.79 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
3.02 | 18720364 17596541 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.37 | 19299654 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.34 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.87 | 20007298 15890375 16377806 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
4.04 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
4.04 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
ciglitazone |
4.04 | 15899809 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
2.93 | 18176117 18332650 15577323 12374674 16809738 16248763 15577320 17761969 16432458 18505091 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.35 | 19299654 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
4.08 | 18443271 19549372 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.72 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
4.09 | 17611569 19805378 17596541 18720364 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.20 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.08 | 16411023 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
5.48 | 16946489 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.48 | 17405874 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
3.93 | 15176712 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.75 | 17378895 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
6.27 | 16144296 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
4.10 | 18324645 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.46 | 19058328 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.26 | 15577323 |